F32.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Sufficient knowledge of German Ability to consent Voluntary treatment Diagnosis of a depressive episode No diagnosed, current addiction disorder (nicotine, alcohol, illegal drugs) No contraindication to exercise Stable long-term medication (one week) BMI 1 cup of black or green tea/day, daily consumption of energy drinks or dietary supplements containing caffeine
Exclusion criteria
Exclusion criteria: Age 65 years Lack of knowledge of German Lack of ability to consent Involuntary treatment Diagnosed current addiction disorder (nicotine, alcohol, illegal drugs) Contraindications to physical exercise Pregnancy and breast feeding period Taking steroids during the study period Known high consumption of other caffeinated drinks or Food (> 1 cup of black or green tea/day, daily consumption of energy drinks or dietary supplements with caffeine) Relevant orthopedic or internal diseases that prevent cardiopulmonary exercise
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is VO2max (maximum oxygen uptake) and is measured using spiroergometry. Spiroergometry is a diagnostic procedure in which the reaction of the heart, circulation, breathing and metabolism as well as performance is examined by measuring respiratory gases during physical exertion. This parameter is collected at the baseline visit at the beginning and at the follow-up visit after the 12-week intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints are mentioned below and the respective measurement method is mentioned in brackets: Strength (hand dynamometry, standing broad jump) Muscular endurance (bent arm hang, sit-ups) Speed (Plate Tapping) Flexibility (Sit and Reach Test) Balance (Flamingo Balance Test) (objective) physical activity & mobility (IPAQ, pedometer Actigraph) Vital signs (blood pressure monitor, body scale) Body fat measurement (Caliper) Functional Level & Quality of Life (GAF) Mood (BDI, HAMD, PANAS, PHQ-9) Cognition (TMT A/B) Nutrition/caffeine (protocol management) Endocrinological (blood value Apelin (EDTA)) Cardiological (long-term ECG, echo) All parameters are collected at the baseline visit at the beginning and at the follow-up visit after the 12-week intervention. | — |
Countries
Germany
Contacts
Klinik für Psychiatrie, Psychotherapie und Psychosomatik der Universität Augsburg